Sh3rf2/POSHER Protein Promotes Cell Survival by Ring-mediated Proteasomal Degradation of the c-Jun N-terminal Kinase Scaffold POSH (Plenty of SH3s) Protein

被引:25
|
作者
Wilhelm, Michael [1 ,2 ]
Kukekov, Nickolay V. [3 ]
Schmit, Travis L. [1 ]
Biagas, Katherine V. [2 ]
Sproul, Andrew A. [3 ]
Gire, Stephen [2 ]
Maes, Margaret E. [1 ]
Xu, Zhiheng [3 ]
Greene, Lloyd A. [3 ]
机构
[1] Univ Wisconsin Madison, Dept Pediat, Madison, WI 53792 USA
[2] Columbia Univ Hlth Sci, Dept Pediat, New York, NY 10032 USA
[3] Columbia Univ Hlth Sci, Dept Pathol & Cell Biol, New York, NY 10032 USA
基金
美国国家卫生研究院;
关键词
JNK ACTIVATION; SYMPATHETIC NEURONS; PEPTIDE INHIBITOR; CEREBRAL-ISCHEMIA; APOPTOSIS; DEATH; PATHWAY; STRESS; IDENTIFICATION; EXCITOTOXICITY;
D O I
10.1074/jbc.M111.269431
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We report that Sh3rf2, a homologue of the pro-apoptotic scaffold POSH (Plenty of SH3s), acts as an anti-apoptotic regulator for the c-Jun N-terminal kinase (JNK) pathway. siRNA-mediated knockdown of Sh3rf2 promotes apoptosis of neuronal PC12 cells, cultured cortical neurons, and C6 glioma cells. This death appears to result from activation of JNK signaling. Loss of Sh3rf2 triggers activation of JNK and its target c-Jun. Also, apoptosis promoted by Sh3rf2 knockdown is inhibited by dominant-negative c-Jun as well as by a JNK inhibitor. Investigation of the mechanism by which Sh3rf2 regulates cell survival implicates POSH, a scaffold required for activation of pro-apoptotic JNK/c-Jun signaling. In cells lacking POSH, Sh3rf2 knockdown is unable to activate JNK. We further find that Sh3rf2 binds POSH to reduce its levels by a mechanism that requires the RING domains of both proteins and that appears to involve proteasomal POSH degradation. Conversely, knockdown of Sh3rf2 promotes the stabilization of POSH protein and activation of JNK signaling. Finally, we show that endogenous Sh3rf2 protein rapidly decreases following several different apoptotic stimuli and that knockdown of Sh3rf2 activates the proapoptotic JNK pathway in neuronal cells. These findings support a model in which Sh3rf2 promotes proteasomal degradation of pro-apoptotic POSH in healthy cells and in which apoptotic stimuli lead to rapid loss of Sh3rf2 expression, and consequently to stabilization of POSH and JNK activation and cell death. On the basis of these observations, we propose the alter-native name POSHER (POSH-eliminating RING protein) for the Sh3rf2 protein.
引用
收藏
页码:2247 / 2256
页数:10
相关论文
共 37 条
  • [31] Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry:: Differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3β
    Reynolds, CH
    Betts, JC
    Blackstock, WP
    Nebreda, AR
    Anderton, BH
    JOURNAL OF NEUROCHEMISTRY, 2000, 74 (04) : 1587 - 1595
  • [32] Protective effect of the poly(ADP-ribose) polymerase inhibitor PJ34 on mitochondrial depolarization-mediated cell death in hepatocellular carcinoma cells involves attenuation of c-Jun N-terminal kinase-2 and protein kinase B/Akt activation
    Radnai, Balazs
    Antus, Csenge
    Racz, Boglarka
    Engelmann, Peter
    Priber, Janos Krisztian
    Tucsek, Zsuzsanna
    Veres, Balazs
    Turi, Zsuzsanna
    Lorand, Tamas
    Sumegi, Balazs
    Gallyas, Ferenc, Jr.
    MOLECULAR CANCER, 2012, 11
  • [33] Protective effect of the poly(ADP-ribose) polymerase inhibitor PJ34 on mitochondrial depolarization-mediated cell death in hepatocellular carcinoma cells involves attenuation of c-Jun N-terminal kinase-2 and protein kinase B/Akt activation
    Balazs Radnai
    Csenge Antus
    Boglarka Racz
    Peter Engelmann
    Janos Krisztian Priber
    Zsuzsanna Tucsek
    Balazs Veres
    Zsuzsanna Turi
    Tamas Lorand
    Balazs Sumegi
    Ferenc Gallyas
    Molecular Cancer, 11
  • [34] Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis
    Saeki, K
    Kobayashi, N
    Inazawa, Y
    Zhang, H
    Nishitoh, H
    Ichijo, H
    Saeki, K
    Isemura, M
    Yuo, A
    BIOCHEMICAL JOURNAL, 2002, 368 (03) : 705 - 720
  • [35] TNF receptor family member BCMA (B cell maturation) associates with TNF receptor-associated factor (TRAF) 1, TRAF2, and TRAF3 and activates NF-κB, Elk-1, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase
    Hatzoglou, A
    Roussel, J
    Bourgeade, MF
    Rogier, E
    Madry, C
    Inoue, J
    Devergne, O
    Tsapis, A
    JOURNAL OF IMMUNOLOGY, 2000, 165 (03): : 1322 - 1330
  • [36] Biphasic activation of apoptosis signal-regulating kinase 1-stress-activated protein kinase 1-c-Jun N-terminal protein kinase pathway is selectively mediated by Ca2+-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors involving oxidative stress following brain ischernia in rat hippocampus
    Zhang, QG
    Zhang, GY
    Meng, FJ
    Tian, H
    NEUROSCIENCE LETTERS, 2003, 337 (01) : 51 - 55
  • [37] Cyclooxygenase-2 inhibitor SC-236 [4-[5-(4-chlorophenyl)-3-(trifluoromethyl)-1-pyrazol-1-I] benzenesulfonamide] suppresses nuclear factor-κB activation and phosphorylation of p38 mitogen-activated protein kinase, extracellular signal regulated kinase, and c-Jun N-terminal kinase in human mast cell line cells
    Kim, SJ
    Jeong, HJ
    Choi, IY
    Lee, KM
    Park, RK
    Hong, SH
    Kim, HM
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 314 (01): : 27 - 34